zidovudine has been researched along with HIV Wasting Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brophy, JC; Chan, AK; Hawkes, MT; Mateyu, G; Mwinjiwa, E; Sodhi, SK | 1 |
| Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS | 1 |
| Bruno, F; Gastaut, JA; Lang, JM; Partisani, M; Poizot-Martin, I; Rouviere, O; Saint-Marc, T; Touraine, JL | 1 |
| Macallan, DC; Sheehan, LA | 1 |
| James, IR; John, M; Mallal, SA; McKinnon, EJ; Moore, CB | 1 |
8 other study(ies) available for zidovudine and HIV Wasting Syndrome
| Article | Year |
|---|---|
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Dideoxynucleotides; Female; HIV Infections; HIV Wasting Syndrome; Humans; Infant; Lamivudine; Malawi; Male; Proportional Hazards Models; Retrospective Studies; Rural Population; Stavudine; Survival Analysis; Tuberculosis, Pulmonary; Zidovudine | 2016 |
Fat wasting--AZT vs. d4T.
Topics: HIV Infections; HIV Wasting Syndrome; Humans; Male; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2002 |
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Cross-Sectional Studies; Energy Intake; Female; Glucose Tolerance Test; HIV Infections; HIV Wasting Syndrome; Humans; Lipids; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Syndrome; Zidovudine | 1999 |
Determinants of energy intake and energy expenditure in HIV and AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Appetite; Body Weight; CD4 Lymphocyte Count; Energy Intake; Energy Metabolism; Exercise; Fever; HIV Wasting Syndrome; Humans; Longitudinal Studies; Male; Prospective Studies; Regression Analysis; Zidovudine | 2000 |
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cohort Studies; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors; Zidovudine | 2000 |
Weight loss update.
Topics: AIDS-Related Opportunistic Infections; Appetite Stimulants; Female; Growth Hormone; HIV Infections; HIV Wasting Syndrome; Humans; Male; Recombinant Proteins; Testosterone; Thalidomide; Weight Loss; Zidovudine | 1996 |
New developments in women and AIDS research.
Topics: AIDS-Related Opportunistic Infections; Delavirdine; Drug Therapy, Combination; Estrogens; Female; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Indoles; Infant; Infectious Disease Transmission, Vertical; Isoquinolines; Nelfinavir; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Sulfonic Acids; Zidovudine | 1997 |